Photo by freestocks from unsplash
A novel Russian medicine dimephosphonum at its therapeutic doses of 50 mg/kg and 100 mg/kg showed anti-seizure activity on models of primary generalized seizures caused by corazolum or by maximal electroshock in… Click to show full abstract
A novel Russian medicine dimephosphonum at its therapeutic doses of 50 mg/kg and 100 mg/kg showed anti-seizure activity on models of primary generalized seizures caused by corazolum or by maximal electroshock in rats and mice. Dimephosphonum prevented death of rats and mice in both seizure models like reference preparations phenazepam, valproic acid, and levetiracetam. The effects of dimephosphonum were less pronounced compared to phenazepam or valproic acid, but were comparable to those of levetiracetam.
Journal Title: BioNanoScience
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!